Available online at: August 11, 2025) A Randomized, Double-Blind, Placebo Controlled, Parallel Groups Study on Efficacy and Safety of nac 600 mg Daily and nac 1200 mg Daily as Mucolytic Agent in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
Some use it as a supervised injectable for deeper recovery goals
Since its 2020 launch, Auros sales have doubled every year
Beyond nutrient preservation, synergistic interactions are pivotal for enhancing nutrient liberation and utilization
GHK-Cu delivers copper as a cofactor for lysyl oxidase and lysyl hydroxylase, two enzymes essential for crosslinking collagen chains into stable, load-bearing structures
We intentionally designed our serums to work perfectly together, as well as with your lifestyle